Found: 37
Select item for more details and to access through your institution.
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Effect of topical chamomile on immunohistochemical levels of IL-1[beta] and TNF-[alpha] in 5-fluorouracil-induced oral mucositis in hamsters.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Effect of topical chamomile on immunohistochemical levels of IL-1β and TNF-α in 5-fluorouracil-induced oral mucositis in hamsters.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 293, doi. 10.1007/s00280-012-2013-9
- By:
- Publication type:
- Article
Triplet combination with paclitaxel, cisplatin and 5-FU is effective in metastatic and/or recurrent nasopharyngeal carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 371, doi. 10.1007/s00280-012-2020-x
- By:
- Publication type:
- Article
The anti-cancer activities of jasmonates.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 275, doi. 10.1007/s00280-012-2039-z
- By:
- Publication type:
- Article
Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 441, doi. 10.1007/s00280-012-2024-6
- By:
- Publication type:
- Article
Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 537, doi. 10.1007/s00280-012-2036-2
- By:
- Publication type:
- Article
A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 463, doi. 10.1007/s00280-012-2019-3
- By:
- Publication type:
- Article
Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 361, doi. 10.1007/s00280-012-2018-4
- By:
- Publication type:
- Article
Amelioration of cisplatin-induced nephrotoxicity in peroxiredoxin I-deficient mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 503, doi. 10.1007/s00280-012-2046-0
- By:
- Publication type:
- Article
Incidence and risk of hypertension with pazopanib in patients with cancer: a meta-analysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 431, doi. 10.1007/s00280-012-2025-5
- By:
- Publication type:
- Article
Erratum to: Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Combination of three cytotoxic agents in small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 413, doi. 10.1007/s00280-012-2022-8
- By:
- Publication type:
- Article
CYP2D6 phenotype indicative for optimized antiestrogen efficacy associates with outcome in early breast cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 301, doi. 10.1007/s00280-012-2003-y
- By:
- Publication type:
- Article
Pharmacokinetic study and effectiveness evaluation of slow-release PLGA-5-fluorouracil microsphere.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 351, doi. 10.1007/s00280-012-2016-6
- By:
- Publication type:
- Article
Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 457, doi. 10.1007/s00280-012-2026-4
- By:
- Publication type:
- Article
A phase I dose-escalation trial of 2-deoxy- d-glucose alone or combined with docetaxel in patients with advanced solid tumors.
- Published in:
- 2013
- By:
- Publication type:
- Report
Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liver.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 389, doi. 10.1007/s00280-012-2014-8
- By:
- Publication type:
- Article
Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 531, doi. 10.1007/s00280-012-2035-3
- By:
- Publication type:
- Article
Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 345, doi. 10.1007/s00280-012-2011-y
- By:
- Publication type:
- Article
Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 399, doi. 10.1007/s00280-012-2015-7
- By:
- Publication type:
- Article
Erratum to: Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
A phase I trial of imatinib in combination with mFOLFOX6-bevacizumab in patients with advanced colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 321, doi. 10.1007/s00280-012-2009-5
- By:
- Publication type:
- Article
A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory to or progressive after first-line chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 481, doi. 10.1007/s00280-012-2027-3
- By:
- Publication type:
- Article
In vitro and in vivo studies of pharmacokinetics and antitumor efficacy of D07001-F4, an oral gemcitabine formulation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 379, doi. 10.1007/s00280-012-2017-5
- By:
- Publication type:
- Article
Absorption, metabolism and excretion of [C]pomalidomide in humans following oral administration.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 489, doi. 10.1007/s00280-012-2040-6
- By:
- Publication type:
- Article
Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 511, doi. 10.1007/s00280-012-2041-5
- By:
- Publication type:
- Article
Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 307, doi. 10.1007/s00280-012-2008-6
- By:
- Publication type:
- Article
Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [F]-FDG incorporation and changes in P-NMR-detectable phosphomonoesters.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 473, doi. 10.1007/s00280-012-2032-6
- By:
- Publication type:
- Article
In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenografts.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 331, doi. 10.1007/s00280-012-2010-z
- By:
- Publication type:
- Article
Comparison of pharmacokinetics and safety profiles of two capecitabine tablet formulations in patients with colon, colorectal or breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 287, doi. 10.1007/s00280-012-2007-7
- By:
- Publication type:
- Article
Association between bevacizumab-related hypertension and vascular endothelial growth factor (VEGF) gene polymorphisms in Japanese patients with metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 405, doi. 10.1007/s00280-012-2028-2
- By:
- Publication type:
- Article
Early initiation of adjuvant chemotherapy improves survival of patients with pancreatic carcinoma after surgical resection.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 419, doi. 10.1007/s00280-012-2029-1
- By:
- Publication type:
- Article
Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 543, doi. 10.1007/s00280-012-2038-0
- By:
- Publication type:
- Article